Cytomegalovirus Infection: Advancing Strategies for Prevention and Treatment

September 4-6, 2018


Maternal and Pediatric Infectious Disease Branch (MPIDB), NICHD
National Institute of Allergy and Infectious Diseases


Fishers Lane Conference Center, Room 1D13, 5601 Fishers Lane, Rockville, Maryland 20852


Cytomegalovirus (CMV) causes significant health problems for infants who were infected in the womb and for people who become infected from organ or stem cell transplants. There is no licensed vaccine for CMV. Treatment of CMV infection is challenging because of the side effects of antiviral drugs and the emergence of drug-resistant strains. New approaches for both prevention and treatment will have a substantial public health impact.


Nahida Chakhtoura, NICHD

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of pageBACK TO TOP